Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Virtual Reality Glasses Used in Gynecologic Cancer Patients Receiving Chemotherapy on Treatment Compliance and Anxiety Level.

NCT06760689 is registered in ClinicalTrials.gov with Çankırı Karatekin University as lead sponsor.

NCT NCT06760689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06760689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Virtual Reality Glasses Used in Gynecologic Cancer Patients Receiving Chemotherapy on Treatment Compliance and Anxiety Level.
Lead sponsor
Çankırı Karatekin University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 1, 2024
Completion date
July 31, 2025
Enrollment
118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, gynecologic cancers